Proinflammatory Cytokines Impair Vitamin D‐Induced Host Defense in Cultured Airway Epithelial Cells

&NA; Vitamin D is a regulator of host defense against infections and induces expression of the antimicrobial peptide hCAP18/LL‐37. Vitamin D deficiency is associated with chronic inflammatory lung diseases and respiratory infections. However, it is incompletely understood if and how (chronic) airway inflammation affects vitamin D metabolism and action. We hypothesized that long‐term exposure of primary bronchial epithelial cells to proinflammatory cytokines alters their vitamin D metabolism, antibacterial activity, and expression of hCAP18/LL‐37. To investigate this, primary bronchial epithelial cells were differentiated at the air‐liquid interface for 14 days in the presence of the proinflammatory cytokines, TNF‐&agr; and IL‐1&bgr; (TNF‐&agr;/IL‐1&bgr;), and subsequently exposed to vitamin D (inactive 25(OH)D3 and active 1,25(OH)2D3). Expression of hCAP18/LL‐37, vitamin D receptor, and enzymes involved in vitamin D metabolism (CYP24A1 and CYP27B1) was determined using quantitative PCR, Western blot, and immunofluorescence staining. Furthermore, vitamin D‐mediated antibacterial activity was assessed using nontypeable Haemophilus influenzae. We found that TNF‐&agr;/IL‐1&bgr; treatment reduced vitamin D‐induced expression of hCAP18/LL‐37 and killing of nontypeable H. influenzae. In addition, CYP24A1 (a vitamin D‐degrading enzyme) was increased by TNF‐&agr;/IL‐1&bgr;, whereas CYP27B1 (that converts 25(OH)D3 to its active form) and vitamin D receptor expression remained unaffected. Furthermore, we have demonstrated that the TNF‐&agr;/IL‐1&bgr;‐mediated induction of CYP24A1 was, at least in part, mediated by the transcription factor specific protein 1, and the epidermal growth factor receptor‐mitogen‐activated protein kinase pathway. These findings indicate that TNF‐&agr;/IL‐1&bgr; decreases vitamin D‐mediated antibacterial activity and hCAP18/LL‐37 expression via induction of CYP24A1 and suggest that chronic inflammation impairs protective responses induced by vitamin D.

[1]  V. Tangpricha,et al.  Treatment of vitamin D deficiency in cystic fibrosis , 2016, The Journal of Steroid Biochemistry and Molecular Biology.

[2]  John H. White,et al.  Species-specific regulation of innate immunity by vitamin D signaling , 2016, The Journal of Steroid Biochemistry and Molecular Biology.

[3]  J. Fichna,et al.  LL-37: Cathelicidin-related antimicrobial peptide with pleiotropic activity , 2016, Pharmacological reports : PR.

[4]  D. Knight,et al.  Elucidating novel disease mechanisms in severe asthma , 2016, Clinical & translational immunology.

[5]  R. Koren,et al.  TNF-α increases the expression and activity of vitamin D receptor in keratinocytes: role of c-Jun N-terminal kinase , 2016, Dermato-endocrinology.

[6]  M. Henket,et al.  Detailed analysis of sputum and systemic inflammation in asthma phenotypes: are paucigranulocytic asthmatics really non-inflammatory? , 2015, BMC Pulmonary Medicine.

[7]  P. Dhawan,et al.  Vitamin D: Metabolism, Molecular Mechanism of Action, and Pleiotropic Effects. , 2016, Physiological reviews.

[8]  Jodie L Simpson,et al.  Airway dysbiosis: Haemophilus influenzae and Tropheryma in poorly controlled asthma , 2015, European Respiratory Journal.

[9]  P. King,et al.  The Lung Immune Response to Nontypeable Haemophilus influenzae (Lung Immunity to NTHi) , 2015, Journal of immunology research.

[10]  W. Janssens,et al.  Innate Immune Modulation in Chronic Obstructive Pulmonary Disease: Moving Closer toward Vitamin D Therapy , 2015, The Journal of Pharmacology and Experimental Therapeutics.

[11]  Ting Wu,et al.  Activation of Vitamin D Regulates Response of Human Bronchial Epithelial Cells to Aspergillus fumigatus in an Autocrine Fashion , 2015, Mediators of inflammation.

[12]  Aditya K. Gupta,et al.  The Rise and Fall of Oral Ketoconazole , 2015, Journal of cutaneous medicine and surgery.

[13]  R. Bals,et al.  The innate immune function of airway epithelial cells in inflammatory lung disease , 2015, European Respiratory Journal.

[14]  David A. Jolliffe,et al.  Vitamin D3 supplementation in patients with chronic obstructive pulmonary disease (ViDiCO): a multicentre, double-blind, randomised controlled trial. , 2015, The Lancet. Respiratory medicine.

[15]  S. Suissa,et al.  Inhaled corticosteroids in COPD: the clinical evidence , 2014, European Respiratory Journal.

[16]  F. Larrea,et al.  Regulation of CYP27B1 and CYP24A1 gene expression by recombinant pro-inflammatory cytokines in cultured human trophoblasts , 2014, The Journal of Steroid Biochemistry and Molecular Biology.

[17]  H. DeLuca,et al.  Small-molecule inhibitors of 25-hydroxyvitamin D-24-hydroxylase (CYP24A1): synthesis and biological evaluation. , 2014, Journal of medicinal chemistry.

[18]  M. Lamkanfi,et al.  Inflammasomes in respiratory disease: from bench to bedside. , 2014, Chest.

[19]  Wu Zhang,et al.  Effects of 25-hydroxyvitamin D3 on cathelicidin production and antibacterial function of human oral keratinocytes. , 2013, Cellular immunology.

[20]  M. Rosenthal,et al.  IL-17 in lung disease: friend or foe? , 2013, Thorax.

[21]  S. Spector,et al.  Toll-Like Receptor 8 Ligands Activate a Vitamin D Mediated Autophagic Response that Inhibits Human Immunodeficiency Virus Type 1 , 2012, PLoS pathogens.

[22]  P. Hiemstra,et al.  Interleukin 13 Exposure Enhances Vitamin D-Mediated Expression of the Human Cathelicidin Antimicrobial Peptide 18/LL-37 in Bronchial Epithelial Cells , 2012, Infection and Immunity.

[23]  L. Khachigian,et al.  IL-1beta Signals through the EGF Receptor and Activates Egr-1 through MMP-ADAM , 2012, PloS one.

[24]  M. Welsh,et al.  Reduced Airway Surface pH Impairs Bacterial Killing in the Porcine Cystic Fibrosis Lung , 2012, Nature.

[25]  R. Gallo,et al.  Doxycycline Indirectly Inhibits Proteolytic Activation of Tryptic Kallikrein-Related Peptidases and Activation of Cathelicidin , 2012, The Journal of investigative dermatology.

[26]  M. Decramer,et al.  High Doses of Vitamin D to Reduce Exacerbations in Chronic Obstructive Pulmonary Disease: A Randomized Trial , 2012 .

[27]  G. Joos,et al.  Chronic Obstructive Pulmonary Disease 1 New insights into the immunology of chronic obstructive pulmonary disease , 2011 .

[28]  T. Greulich,et al.  The role of vitamin D in pulmonary disease: COPD, asthma, infection, and cancer , 2011, Respiratory research.

[29]  H. Sakurai,et al.  TAK1-Mediated Serine/Threonine Phosphorylation of Epidermal Growth Factor Receptor via p38/Extracellular Signal-Regulated Kinase: NF-κB-Independent Survival Pathways in Tumor Necrosis Factor Alpha Signaling , 2009, Molecular and Cellular Biology.

[30]  Yan Zhao,et al.  Effects of MAPK signaling on 1,25‐dihydroxyvitamin D‐mediated CYP24 gene expression in the enterocyte‐like cell line, Caco‐2 , 2009, Journal of cellular physiology.

[31]  Alex J. Brown,et al.  Vitamin D analogs: therapeutic applications and mechanisms for selectivity. , 2008, Molecular aspects of medicine.

[32]  G. Hunninghake,et al.  Respiratory Epithelial Cells Convert Inactive Vitamin D to Its Active Form: Potential Effects on Host Defense1 , 2008, The Journal of Immunology.

[33]  F. Karadağ,et al.  Biomarkers of Systemic Inflammation in Stable and Exacerbation Phases of COPD , 2008, Lung.

[34]  A. Saha,et al.  The role of Sp1 in IL-1beta and H. pylori-mediated regulation of H,K-ATPase gene transcription. , 2008, American journal of physiology. Gastrointestinal and liver physiology.

[35]  M. Berger,et al.  Chronic Inflammation in the Cystic Fibrosis Lung: Alterations in Inter- and Intracellular Signaling , 2008, Clinical reviews in allergy & immunology.

[36]  P. Dhawan,et al.  Induction of cathelicidin in normal and CF bronchial epithelial cells by 1,25-dihydroxyvitamin D(3). , 2007, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.

[37]  E. Lillehoj,et al.  TNF-alpha induces MUC1 gene transcription in lung epithelial cells: its signaling pathway and biological implication. , 2007, American journal of physiology. Lung cellular and molecular physiology.

[38]  K. Tashiro,et al.  Role of distal upstream sequence in vitamin D-induced expression of human CYP24 gene. , 2007, Biochemical and biophysical research communications.

[39]  R. Bals,et al.  The antimicrobial peptide cathelicidin interacts with airway mucus , 2006, Peptides.

[40]  T. Mukherjee,et al.  Role of TNFα in pulmonary pathophysiology , 2006, Respiratory Research.

[41]  H. Kubo,et al.  IL-17A promotes the growth of airway epithelial cells through ERK-dependent signaling pathway. , 2006, Biochemical and biophysical research communications.

[42]  K. Mandal,et al.  Involvement of the Antimicrobial Peptide LL-37 in Human Atherosclerosis , 2006, Arteriosclerosis, thrombosis, and vascular biology.

[43]  J. Adams,et al.  Toll-Like Receptor Triggering of a Vitamin D-Mediated Human Antimicrobial Response , 2006, Science.

[44]  M. Dallman,et al.  Reversing the defective induction of IL-10-secreting regulatory T cells in glucocorticoid-resistant asthma patients. , 2005, The Journal of clinical investigation.

[45]  John H. White,et al.  Large-scale in silico and microarray-based identification of direct 1,25-dihydroxyvitamin D3 target genes. , 2005, Molecular endocrinology.

[46]  John H. White,et al.  Cutting Edge: 1,25-Dihydroxyvitamin D3 Is a Direct Inducer of Antimicrobial Peptide Gene Expression1 , 2004, The Journal of Immunology.

[47]  K. Rabe,et al.  The Antimicrobial Peptide LL-37 Activates Innate Immunity at the Airway Epithelial Surface by Transactivation of the Epidermal Growth Factor Receptor 1 , 2003, The Journal of Immunology.

[48]  Jian-Dong Li,et al.  Up-Regulation of Interleukin-8 by Novel Small Cytoplasmic Molecules of Nontypeable Haemophilus influenzae via p38 and Extracellular Signal-Regulated Kinase Pathways , 2003, Infection and Immunity.

[49]  P. Nussbaumer,et al.  Inhibitors of vitamin D hydroxylases: Structure–activity relationships , 2003, Journal of cellular biochemistry.

[50]  C. Garbe,et al.  Cathelicidin anti-microbial peptide expression in sweat, an innate defense system for the skin. , 2002, The Journal of investigative dermatology.

[51]  J. Calafat,et al.  Human cathelicidin, hCAP-18, is processed to the antimicrobial peptide LL-37 by extracellular cleavage with proteinase 3. , 2001, Blood.

[52]  C. Agustí,et al.  Epidermal growth factor system regulates mucin production in airways. , 1999, Proceedings of the National Academy of Sciences of the United States of America.